CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Shares by Mark Eisenberg 25.06.2024 CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.
ChargePoint Interim CFO Sells $26K Stock Amid Revenue Forecasts by Mark Eisenberg 22.06.2024 ChargePoint Interim CFO Mansi Khetani sells $26k in stock to cover taxes, holds 402k+ shares. Company reports $107M Q1 revenue ...
ChargePoint CCXO Sells $13K Shares Amidst EBITDA Loss by Mark Eisenberg 22.06.2024 Jagdeep Singh, ChargePoint CCO, sells 9,389 shares at $1.3971 each to cover taxes, holding 886,364 shares, indicating confidence in company’s ...
System1 CEO Michael Blend Sells $1.08M in Shares by Mark Eisenberg 22.06.2024 System1 CEO Michael Blend sells $1.08M in shares, transferring to CEE Holdings Trust. Key financial and governance changes outlined.
Lone Star Trust Sells System1 Shares for $7.16M by Mark Eisenberg 22.06.2024 Lone Star Friends Trust sells 4.775M shares of System1, Inc. for $7.16M in a major transaction. Future strategies focus on ...
Levi Strauss Maintains Buy Rating Amid Positive Market Sentiment by Mark Eisenberg 22.06.2024 Levi Strauss stock holds a Buy rating from UBS at a $25 target. Stable investor sentiment, strategic growth moves, and ...
International Seaways Exec Sells $414K in Stock Amid Q1 Gains by Mark Eisenberg 18.06.2024 "James D. Small III, CAO of International Seaways, sells $414k in stock amid company's robust Q1 2024 performance. Investors take ...
Sacks Parente Golf Director Purchases 30,833 Shares by Mark Eisenberg 18.06.2024 Sacks Parente Golf sees confidence boost as Director Brett Widney invests $15K, highlighting growth potential despite past stock volatility.
Deutsche Bank Boosts Oracle Shares, Highlights Growth Potential by Lilu Anderson 17.06.2024 Deutsche Bank's 3% DCF growth rate signals GDP alignment; Analyst warns Oracle's rating, target price risks. AI-assisted, editor-reviewed. Learn more ...
Madrigal Pharma Exec Sells $570K in Stock Amid Analyst Focus by Mark Eisenberg 15.06.2024 Waltermire sells 2,000 shares at $285 each, netting $570K; Madrigal Pharmaceuticals sees mixed analyst reports with H.C. Wainwright lowering its ...